IL-17A has already been implicated in the pathogenesis of various autoimmune diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) where increased serum and tissue levels of IL-17A have been found, and higher serum levels correlated with disease activity in patients [21,22]. This evidence concerns the gene IL17A and autoimmune disease.